Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of adult acute myelogenous leukemia in first complete remission

Leukemia

Volumn 17, Issue 11, 2003, Pages 2183-2188

  Collisson, E A ^a,b   Lashkari, A ^a   Malone, R ^a   Paquette, R ^a   Emmanouilides, C ^a   Territo, M C ^a   Schiller, G J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c CHS   (United States)

Author keywords

Acute myelogenous leukemia; Autologous transplantation; First complete remission

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; FLUCONAZOLE; IDARUBICIN; IMIPENEM; MITOXANTRONE; NORFLOXACIN; NYSTATIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SULPERAZON;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KARYOTYPE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; PERIPHERAL BLOOD STEM CELL; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; STEM CELL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0242558971     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403126     Document Type: Article

References (42)

1. Cassileth PA, Begg CB, Bennett JM, Bozdech M, Kahn SB, Weiler C et al. A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia. Blood 1984; 63: 843-847.
2. Preisler HD, Raza A, Early A, Kirshner J, Brecher M, Freeman A et al. Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia. J Clin Oncol 1987; 5: 722-730.
3. Phillips GL, Shepherd JD, Barnett MJ, Brown RA, Frei-Lahr DA, Klingemann HG et al. High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults. Blood 1991; 77: 1429-1435.
4. Appelbaum FR, Dahlberg S, Thomas ED, Buckner CD, Cheever MA, Clift RA et al. Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparison. Ann Intern Med 1984; 101: 581-588.
5. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med 1994; 331: 896-903.
6. Schiffer CA, Dodge R, Larson RA. Long-term follow-up of Cancer and Leukemia Group B studies in acute myeloid leukemia. Cancer 1997; 80 (Suppl.): 2210-2214.
7. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995; 86: 2041-2050.
8. Berman E, Little C, Gee T, O'Reilly R, Clarkson B. Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation. N Engl J Med 1992; 326: 156-160.
9. Lowenberg B, Verdonck LJ, Dekker AW, Willemze R, Zwaan FE, de Planque M et al. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study. J Clin Oncol 1990; 8: 287-294.
10. Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman P et al. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. N Engl J Med 1995; 332: 1671-1677.
11. Laporte JP, Douay L, Lopez M, Labopin M, Jouet JP, Lesage S et al. One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience. Blood 1994; 84: 3810-3818.
12. Mehta J, Powles R, Singhal S, Horton C, Tait D, Milan S et al. Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factors. Bone Marrow Transplant 1995; 16: 499-506.
13. Bensinger WI, Deeg HJ. Blood or marrow? Lancet 2000; 355: 1199-1200.
14. Stein AS, Chai A, Schmidt GM, Nademanee A, Parker PM, Smith EP et al. In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission. J Clin Oncol 1996; 14: 2206-2216.
15. Reiffers J, Labopin M, Sanz M, Korbling M, Blaise D, De La Rubia J et al. Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis. Bone Marrow Transplant 2000; 25: 1115-1119.
16. Bennett JM, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1977; 33: 451-458.
17. Schiller G, Territo M, Nimer S, Lee M, Belin T, Champlin R. Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia. Blood 1992; 80: 2977-2982.
18. Schiller GJ, Nimer SD, Territo MC, Ho WG, Champlin RE, Gajewski JL. Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission. J Clin Oncol 1992; 10: 41-46.
19. Ellison RR, Holland JF, Weil M, Jacquillat C, Boiron M, Bernard J et al. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood 1968; 32: 507-523.
20. Schiller G, Wong S, Lowe T, Snead G, Paquette R, Sawyers C et al. Transplantation of IL-2-mobilized autologous peripheral blood progenitor cells for adults with acute myelogenous leukemia in first remission. Leukemia 2001; 15: 757-763.
21. Sun GX, Gale RP, Sparkes RS, Schreck RR. Use of conditioned media in cell culture can mask cytogenetic abnormalities in acute leukemia. Cancer Genet Cytogenet 1990; 46: 107-113.
22. Dinse GE, Lagakos SW. Nonparametric estimation of lifetime and disease onset distributions from incomplete observations. Biometrics 1982; 38: 921-932.
23. Allison P. Survival Analysis Using the SAS System: A Practical Guide. Cary, NC, 1998, SAS Publishing.
24. Schiffer CA. Acute myeloid leukemia in adults: where do we go from here? Cancer Chemother Pharmacol 2001; 48: S45-S52.
25. Hiddemann W. Treatment strategies in acute myeloid leukemia (AML). B. Second line treatment. Blut 1990; 60: 163-171.
26. Wolff SN, Fay JW, Phillips GL, Lazarus HM, Flexner JM, Stein RS et al. High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results. J Clin Oncol 1989; 7: 1260-1267.
27. Spellberg B, Schiller GL. Autologous bone marrow transplantation in acute leukemia. Hematol Oncol Clin N Am 1999; 13: 919-938.
28. Korbling M, Hunstein W, Fliedner TM, Cayeux S, Dorken B, Fehrentz D et al. Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia. Blood 1989; 74: 1898-1904.
29. Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995; 332: 217-223.
30. Harousseau JL, Cahn JY, Pignon B, Witz F, Milpied N, Delain M et al. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM). Blood 1997; 90: 2978-2986.
31. Burnett AK, Goldstone AH, Stevens RM, Hann IM, Rees JK, Gray RG et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties. Lancet 1998; 351: 700-708.
32. Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta. E et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med 1998; 339: 1649-1656.
33. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000; 96: 4075-4083.
34. Burnett AK, Wheatley K, Goldstone AH, Stevens RF, Hann IM, Rees JH et al. The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. Br J Haematol 2002; 118: 385-400.
35. Frassoni F. Randomised studies in acute myeloid leukaemia: the double truth. Bone Marrow Transplant 2000; 25: 471-473.
36. Cahn JY, Labopin M, Schattenberg A, Reiffers J, Willemze R, Zittoun R et al. Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia 1997; 11: 416-419.
37. Cahn JY, Labopin M, Mandelli F, Goldstone AH, Eberhardt K, Reiffers J et al. Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant Group. Blood 1995; 85: 575-579.
38. Sekeres MA. The challenge of acute myeloid leukemia in older patients. Curr Opin Oncol 2002; 14: 24-30.
39. Pinto A, Ferrara F. Acute myeloid leukemia in the elderly: biology and therapeutic strategies. Crit Rev Oncol Hematol 2001; 39: 275-287.
40. Wahlin A, Golovieva I, Nilsson M. Prognostic significance of risk group stratification in elderly patients with acute myeloid leukaemia. Br J Haematol 2001; 115: 25-33.
41. Linker CA, Damon LE, Ries CA, Navarro WA, Case D, Wolf JL. Autologous stem cell transplantation for advanced acute myeloid leukemia. Bone Marrow Transplant 2002; 29: 297-301.
42. Gorin NC. Autologous stem cell transplantation for adult acute leukemia. Curr Opin Oncol 2002; 14: 152-159.